Products Factory | China Products Manufacturers, Suppliers

Hydrochlorothiazide

API’s Name Indication Specification US DMF EU DMF CEP

Hydrochlorothiazide Diuretics USP/EP/CEP 16750 √ CEP 2006-011

inquiry detail
Folic Acid

API’s Name Indication Specification US DMF EU DMF CEP

Folic Acid Vitamin USP/EP

inquiry detail
Ezetimibe

API’s Name Indication Specification US DMF EU DMF CEP

Ezetimibe Hyperlipidemia In-House/USP 24511 √

inquiry detail
Enalapril Maleate

API’s Name Indication Specification US DMF EU DMF CEP

Enalapril Maleate Hypertension USP/EP

inquiry detail
Dabigatran Etexilate Mesylate

API’s Name Indication Specification US DMF EU DMF CEP

Dabigatran Etexilate Mesylate Anticoagulant In-House

inquiry detail
Daclatasvir Dihydrochloride

API’s Name Indication Specification US DMF EU DMF CEP

Daclatasvir Dihydrochloride HCV In-House √

inquiry detail
Doxycycline Monohydrate

API’s Name Indication Specification US DMF EU DMF CEP

Doxycycline Mono Antibiotics USP/EP 18959 √

inquiry detail
Doxycycline Hyclate

API’s Name Indication Specification US DMF EU DMF CEP

Doxycycline Hyclate Antibiotics USP/EP 13771 √

inquiry detail
Canagliflozin

API’s Name Indication Specification US DMF EU DMF CEP

Canagliflozin Type 2 diabetes In-House √

inquiry detail
Chlorothiazide

API’s Name Indication Specification US DMF EU DMF CEP

Chlorothiazide Diuretics USP/EP

inquiry detail
Captopril

API’s Name Indication Specification US DMF EU DMF CEP

Captopril Hypertension USP/EP √ √

inquiry detail
Bictegravir 1611493-60-7

API’s Name Indication Innovator Patent Expiry Date(The U.S)

Bictegravir 1611493-60-7 HIV-1 infection Gilead Sciences Dec. 19, 2033

inquiry detail

<< < Previous 1 2 3 4 5 6 Next > >> Page 5 / 6

API’s Name	Indication	Specification	US DMF	EU DMF	CEP
Hydrochlorothiazide	Diuretics	USP/EP/CEP	16750	√	CEP 2006-011

API’s Name	Indication	Innovator	Patent Expiry Date(The U.S)
Bictegravir 1611493-60-7	HIV-1 infection	Gilead Sciences	Dec. 19, 2033